Targeted Binding of PLA Microparticles with Lipid-PEG-tethered Ligands

Overview

Journal Biomaterials

Specialty Biomedical Engineering

Date 2007 Aug 21

PMID 17707503

Citations 26

Authors

Wynter J Duncanson

Michael A Figa

Kevin Hallock

Samuel Zalipsky

James A Hamilton

Joyce Y Wong

Affiliations

Soon will be listed here.

Abstract

Solid core polymeric particles are an attractive delivery vehicle as they can efficiently encapsulate drugs of different physical and chemical characteristics. However, the effective targeting of such particles for therapeutic purposes has been somewhat elusive. Here, we report novel polymeric particles comprised of poly(lactic acid) (PLA) with incorporated poly(ethylene glycol)-lipids (PEG-lipids). Particles are characterized for morphology, surface charge, and composition with field-emission scanning electron microscopy (FESEM), zeta potential measurements, and proton nuclear magnetic resonance ((1)H NMR) spectroscopy, respectively. The surface densities of PEG lipids determined by (1)H NMR and particle size distributions are consistent with scaling theory for adsorption of chains onto a surface. We observe significant binding of liganded PEG-lipid tethers when the molecular weight is greater than the unliganded PEG-lipids for significant binding events. Importantly, the binding is not completely lost when the unliganded PEG molecular weight is greater than the liganded PEG-lipid tether. We observe a similar trend for the lower affinity ligand (thioctic acid), but the degree of binding is significantly lower than the high affinity ligand (biotin). This novel technique used to fabricate these liganded particles combined with the lipid bilayer binding studies provides a platform for systematic optimization of particle binding.

Citing Articles

Poly(lactide)-Based Materials Modified with Biomolecules: A Review.

Swierczynska M, Kudzin M, Chrusciel J Materials (Basel). 2024; 17(21).

PMID: 39517460 PMC: 11546716. DOI: 10.3390/ma17215184.

Microencapsulation of Live Cells in Synthetic Polymer Capsules.

Esfahani R, Jun H, Rahmani S, Miller A, Lahann J ACS Omega. 2018; 2(6):2839-2847.

PMID: 30023677 PMC: 6044854. DOI: 10.1021/acsomega.7b00570.

Impact of ConcanavalinA affinity in the intracellular fate of Protein Corona on Glucosamine Au nanoparticles.

Di Silvio D, Silvestri A, Lay L, Polito L, Moya S Sci Rep. 2018; 8(1):9046.

PMID: 29899359 PMC: 5998083. DOI: 10.1038/s41598-018-27418-w.

Targeting of microbubbles: contrast agents for ultrasound molecular imaging.

Wang S, Hossack J, Klibanov A J Drug Target. 2017; 26(5-6):420-434.

PMID: 29258335 PMC: 6319889. DOI: 10.1080/1061186X.2017.1419362.

Lipogels for Encapsulation of Hydrophilic Proteins and Hydrophobic Small Molecules.

Homyak C, Fernandez A, Touve M, Zhao B, Anson F, Hardy J Biomacromolecules. 2017; 19(1):132-140.

PMID: 29141403 PMC: 6326177. DOI: 10.1021/acs.biomac.7b01300.

References

Moshfeghi A, Peyman G . Micro- and nanoparticulates. Adv Drug Deliv Rev. 2005; 57(14):2047-52. DOI: 10.1016/j.addr.2005.09.006. View

Hrkach J, Peracchia M, Domb A, Lotan N, Langer R . Nanotechnology for biomaterials engineering: structural characterization of amphiphilic polymeric nanoparticles by 1H NMR spectroscopy. Biomaterials. 1997; 18(1):27-30. DOI: 10.1016/s0142-9612(96)00077-4. View

Deshpande D, Blezinger P, Pillai R, Duguid J, Freimark B, Rolland A . Target specific optimization of cationic lipid-based systems for pulmonary gene therapy. Pharm Res. 1998; 15(9):1340-7. DOI: 10.1023/a:1011933117509. View

Fahmy T, Samstein R, Harness C, Saltzman W . Surface modification of biodegradable polyesters with fatty acid conjugates for improved drug targeting. Biomaterials. 2005; 26(28):5727-36. DOI: 10.1016/j.biomaterials.2005.02.025. View

Pfeifer B, Burdick J, Langer R . Formulation and surface modification of poly(ester-anhydride) micro- and nanospheres. Biomaterials. 2004; 26(2):117-24. DOI: 10.1016/j.biomaterials.2004.02.015. View

Chen C, Dormidontova E . Architectural and structural optimization of the protective polymer layer for enhanced targeting. Langmuir. 2005; 21(12):5605-15. DOI: 10.1021/la047109v. View

Saxena V, Sadoqi M, Shao J . Indocyanine green-loaded biodegradable nanoparticles: preparation, physicochemical characterization and in vitro release. Int J Pharm. 2004; 278(2):293-301. DOI: 10.1016/j.ijpharm.2004.03.032. View

Mordon S, Sumian C, Devoisselle J . Site-specific methylene blue delivery to pilosebaceous structures using highly porous nylon microspheres: an experimental evaluation. Lasers Surg Med. 2003; 33(2):119-25. DOI: 10.1002/lsm.10204. View

Illum L, Davis S . The organ uptake of intravenously administered colloidal particles can be altered using a non-ionic surfactant (Poloxamer 338). FEBS Lett. 1984; 167(1):79-82. DOI: 10.1016/0014-5793(84)80836-4. View

10.

Longo G, Szleifer I . Ligand-receptor interactions in tethered polymer layers. Langmuir. 2005; 21(24):11342-51. DOI: 10.1021/la051685p. View

11.

Zalipsky S, Brandeis E, NEWMAN M, Woodle M . Long circulating, cationic liposomes containing amino-PEG-phosphatidylethanolamine. FEBS Lett. 1994; 353(1):71-4. DOI: 10.1016/0014-5793(94)01013-7. View

12.

Wong J, Kuhl T, Israelachvili J, Mullah N, Zalipsky S . Direct measurement of a tethered ligand-receptor interaction potential. Science. 1997; 275(5301):820-2. DOI: 10.1126/science.275.5301.820. View

13.

Ruan G, Feng S . Preparation and characterization of poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid) (PLA-PEG-PLA) microspheres for controlled release of paclitaxel. Biomaterials. 2003; 24(27):5037-44. DOI: 10.1016/s0142-9612(03)00419-8. View

14.

Gunatillake P, Mayadunne R, Adhikari R . Recent developments in biodegradable synthetic polymers. Biotechnol Annu Rev. 2006; 12:301-47. DOI: 10.1016/S1387-2656(06)12009-8. View

15.

Gref R, Couvreur P, Barratt G, Mysiakine E . Surface-engineered nanoparticles for multiple ligand coupling. Biomaterials. 2003; 24(24):4529-37. DOI: 10.1016/s0142-9612(03)00348-x. View

16.

Allen T, Cullis P . Drug delivery systems: entering the mainstream. Science. 2004; 303(5665):1818-22. DOI: 10.1126/science.1095833. View

17.

El-Sherif D, Wheatley M . Development of a novel method for synthesis of a polymeric ultrasound contrast agent. J Biomed Mater Res A. 2003; 66(2):347-55. DOI: 10.1002/jbm.a.10586. View

18.

Gref , Luck , Quellec , MARCHAND , Dellacherie , HARNISCH . 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf B Biointerfaces. 2000; 18(3-4):301-313. DOI: 10.1016/s0927-7765(99)00156-3. View

19.

Gabizon A, Shmeeda H, Horowitz A, Zalipsky S . Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates. Adv Drug Deliv Rev. 2004; 56(8):1177-92. DOI: 10.1016/j.addr.2004.01.011. View

20.

Sakhalkar H, Dalal M, Salem A, Ansari R, Fu J, Kiani M . Leukocyte-inspired biodegradable particles that selectively and avidly adhere to inflamed endothelium in vitro and in vivo. Proc Natl Acad Sci U S A. 2003; 100(26):15895-900. PMC: 307664. DOI: 10.1073/pnas.2631433100. View